Alex Glusker Selected Research

Bevacizumab (Avastin)

1/2019

Transcriptomics-Guided Personalized Prescription of Targeted Therapeutics for Metastatic ALK-Positive Lung Cancer Case Following Recurrence on ALK Inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alex Glusker Research Topics

Disease

2	Neoplasms (Cancer) 01/2020 - 01/2019
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

1	RNA (Ribonucleic Acid)IBA 01/2020
1	RamucirumabIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Docetaxel (Taxotere)FDA Link 01/2019
1	CrizotinibIBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2019

Therapy/Procedure

1	Therapeutics 01/2019
1	Drug Therapy (Chemotherapy) 01/2019